Sotera Health (NASDAQ:SHC – Get Free Report) released its earnings results on Thursday. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.02), Zacks reports. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. Sotera Health updated its FY 2025 guidance to 0.700-0.760 EPS.
Sotera Health Stock Down 10.0 %
Shares of NASDAQ SHC traded down $1.36 during trading on Thursday, hitting $12.28. 3,153,775 shares of the company traded hands, compared to its average volume of 956,965. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The business’s fifty day moving average is $13.48 and its 200 day moving average is $14.54. The firm has a market capitalization of $3.48 billion, a price-to-earnings ratio of 49.12 and a beta of 1.91. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.08.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on SHC shares. Citigroup increased their price target on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Barclays decreased their price target on shares of Sotera Health from $18.00 to $17.00 and set an “overweight” rating for the company in a report on Tuesday, February 18th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group assumed coverage on Sotera Health in a research note on Friday, December 6th. They set a “neutral” rating and a $14.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Sotera Health currently has an average rating of “Moderate Buy” and an average target price of $16.08.
About Sotera Health
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
See Also
- Five stocks we like better than Sotera Health
- When to Sell a Stock for Profit or Loss
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- How Can Investors Benefit From After-Hours Trading
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.
